Trade Agreements: The Export Myth That Masked a National Giveaway

Trade Agreements: The Export Myth That Masked a National Giveaway

For decades, U.S. politicians have sold free trade agreements as a beacon of prosperity for the American economy. The logic was tidy: “Most of the world’s consumers live outside the U.S.—so if we open foreign markets, prosperity will follow.” On paper, it sounded plausible. But in practice, it became one of the most costly economic miscalculations in our modern history.

Copper Crisis: Why the U.S. Must Act Now to Save Its Copper Industry

Copper Crisis: Why the U.S. Must Act Now to Save Its Copper Industry

If America fails to defend its copper industry today, it will lose the industrial backbone for tomorrow’s economy. The combination of speculative arbitrage, Chinese overproduction, and predatory pricing is decimating American copper mills.

Tariff Truths: What the Data Actually Says About Inflation, Revenue, and Reality

Tariff Truths: What the Data Actually Says About Inflation, Revenue, and Reality

Depending on where you get your information, you would be forgiven for believing that we are getting buried by inflation, the stock market is in shambles, and that we need to start hoarding Chinese yuan to pay for our morning lattes.

Domestic Market Share Index Drops Significantly in Q1 2025, Fueled by Pre-Tariff Stockpiling

Domestic Market Share Index Drops Significantly in Q1 2025, Fueled by Pre-Tariff Stockpiling

The CPA Domestic Market Share Index (DMSI) dropped abruptly in the first quarter of 2025 as the massive pre-tariff import surge driven by stockpiling heavily outweighed current U.S. manufacturing output.

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicine. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe.

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

In the U.S. today, frontline cancer treatments are being rationed. ERs are short on sedatives. Amoxicillin—one of the most prescribed antibiotics in the country—has been in critical shortage. These are not temporary disruptions. They reflect a structural breakdown caused by the erosion of America’s pharmaceutical manufacturing base and a decades-long surge in generic drug imports.

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

The American pharmaceutical supply chain has become dangerously dependent on imports and foreign-controlled supply chains. Over the past 20 years, the country has experienced a skyrocketing rate on pharmaceutical imports and increasing foreign reliance.

Big Ag is Dead Wrong on Trade

Big Ag is Dead Wrong on Trade

Feeding America with abundant, healthy, locally-produced food is as important as any trade or industrial goal. Reinforcing our capacity to feed ourselves makes the nation stronger, safer, and more prosperous, whole the Big Ag status quo blindly follows a globalized model that has left far too many American farms behind.